$CYTR Company News Six stocks to watch 3:29 p.
Post# of 102254
Posted On: 08/24/2014 12:24:03 PM
$CYTR Company News
Six stocks to watch 3:29 p.m. Jan. 22, 2014 - The Trading Deck
CytRx's stock spike proves to be no fluke with another 20% share gain 12:39 p.m. Dec. 12, 2013 - Russ Britt
MasterCard, Visa among top S&P gainers; Avon in red 5:27 p.m. Dec. 11, 2013 - Sue Chang
Cancer drug test results send CytRx shares soaring by 75% 11:48 a.m. Dec. 11, 2013 - Russ Britt
CytRx jumps on results of aldoxorubicin trial 10:47 a.m. Dec. 11, 2013 - MarketWatch.com
Yum shares drop on outlook, soft China sales 6:10 p.m. Oct. 8, 2013 - Wallace Witkowski
Six companies unveil share, unit offerings 8:45 a.m. Dec. 7, 2012 - MarketWatch.com
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
CytRx prices offering at 20% discount 11:07 a.m. Oct. 18, 2012 - MarketWatch.com
CytRx down 20.6% in premarket 8:59 a.m. Oct. 18, 2012 - Steve Gelsi
CytRx rallies 27% on drug study update 12:49 p.m. July 25, 2012 - Val Brickates Kennedy
CytRx falls 12% in morning trading 11:02 a.m. June 4, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:40 p.m. April 28, 2011 - Kate Gibson
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:00 p.m. June 30, 2009 - MarketWatch
Drug stocks retract; Vical, Geron, Novavax soar 2:29 p.m. June 30, 2009 - Val Brickates Kennedy
CytRx files FDA report on halted clinical trial 9:16 a.m. June 30, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:39 p.m. Jan. 22, 2008 - MarketWatch
Drug stocks tumble on U.S. economy jitters; CytRx slumps 2:33 p.m. Jan. 22, 2008 - Val Brickates Kennedy
CytRx halts trial of ALS treatment 8:50 a.m. Jan. 22, 2008 - Angela Moore
Three Lessons From The Galena Scandal 11:02 a.m. Aug. 21, 2014 - Seeking Alpha
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 5:22 p.m. Aug. 4, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 11:11 a.m. July 8, 2014 - Barrons.com
Five Analyst Stock Picks With 100% or More Implied Upside 8:31 a.m. June 7, 2014 - 247WallSt.com
Celldex: The Race Leader In Glioblastoma Multiforme 3:17 p.m. May 29, 2014 - Seeking Alpha
Aldoxorubicin increases PFS 7:53 a.m. May 28, 2014 - Seeking Alpha
Six Unusual Hot Stocks on the Move Monday Morning 8:14 a.m. May 5, 2014 - 247WallSt.com
Interesting CYTR Put And Call Options For December 20th 12:51 p.m. April 22, 2014 - TheStreet.com
CytRx shares pop premarket 8:32 a.m. April 3, 2014 - Seeking Alpha
CytRx drug for soft-tissue sarcomas gets orphan status in Europe 8:21 a.m. March 31, 2014 - Seeking Alpha
Behind The Scenes With Proactive, Inovio And Unilife 9:45 a.m. March 27, 2014 - Seeking Alpha
Stock Pumping Is Tainting Many Financial Websites 1:30 p.m. March 25, 2014 - Barrons.com
Seeking Alpha Needs to Take Stock of its Policies 10:07 a.m. March 24, 2014 - Barrons.com
Galena: A Good Investment Gone Bad 9:02 a.m. March 18, 2014 - Seeking Alpha
An Insider's Tale of a Stock Promotion Plan 7:39 p.m. March 14, 2014 - Barrons.com
Behind The Scenes With Dream Team, CytRx And Galena 9:30 a.m. March 13, 2014 - Seeking Alpha
CytRx set to begin phase 3 clinical trial for aldoxorubicin 8:33 a.m. March 5, 2014 - Seeking Alpha
10-K: CYTRX CORP 7:04 a.m. March 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
CytRx's Aldoxorubicin's Potential Is Underestimated, Creating A Buying Opportunity 10:06 a.m. Feb. 7, 2014 - Seeking Alpha
CytRx Flushed Its Shareholders, Even If It Needed the Capital 8:16 a.m. Feb. 1, 2014 - 247WallSt.com
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx CorporationRegarding Possible Breaches of Fiduciary Duty 6:03 p.m. Aug. 11, 2014 - BusinessWire - BZX
Technical Recap on Biotech Equities -- CytRx, AVEO Pharma, Mast Therapeutics, Immunomedics, and Dynavax Technologies 9:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Oral Presentation of CytRx’s Aldoxorubicin Phase 2b Clinical Trial in Soft Tissue Sarcoma Highlighted in The Lancet Oncology 6:00 a.m. Aug. 7, 2014 - BusinessWire - BZX
CytRx Reports 2014 Second Quarter Financial Results 6:00 a.m. Aug. 6, 2014 - BusinessWire - BZX
Former Louisiana Attorney General and KSF Announce Appointment as Lead Counsel in CytRx Securities Fraud Lawsuit: Secondary Offering Shareholders (January 31, 2014) Should Inquire for More Information -- CYTR 6:00 p.m. Aug. 5, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx Corporation Regarding Possible Breaches of Fiduciary Duty 6:56 p.m. July 9, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks -- Research on Insmed, Peregrine Pharma, CytRx, and Celldex Therapeutics 6:40 a.m. June 30, 2014 - PR Newswire - PRF
CytRx Added to Russell 3000® and Russell 2000® Indexes 6:01 a.m. June 30, 2014 - BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos 5:20 a.m. June 12, 2014 - PR Newswire - PRF
CytRx to Present at the Jefferies 2014 Global Healthcare Conference 6:01 a.m. May 29, 2014 - BusinessWire - BZX
CytRx Highlights Aldoxorubicin Data from its Global Phase 2b Clinical Trial in First-Line Soft Tissue Sarcoma 6:01 a.m. May 28, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx Corporation and Certain Officers - CYTR 6:15 p.m. May 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline -- CYTR 11:46 a.m. May 8, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR 12:33 p.m. May 6, 2014 - GlobeNewswire
Hagens Berman: 7 Days Remain Until May 13, 2014 Lead Plaintiff Deadline in CytRx Securities Fraud Class Action 12:26 p.m. May 6, 2014 - PR Newswire - PRF
CytRx Reports Completed Phase 1b/2 Progression-Free Survival and Overall Survival Aldoxorubicin Data in Second-Line Soft Tissue Sarcoma 6:01 a.m. May 5, 2014 - BusinessWire - BZX
Pre-Market Review on Top Gainers -- Research on SouFun Holdings, CytRx, Iridium Communications, and Qihoo 360 Technology 8:12 a.m. May 2, 2014 - PR Newswire - PRF
CYTRX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CytRx Corporation - CYTR 10:01 p.m. May 1, 2014 - GlobeNewswire
CytRx Reports 2014 First Quarter Financial Results 6:02 a.m. May 1, 2014 - BusinessWire - BZX
Six stocks to watch 3:29 p.m. Jan. 22, 2014 - The Trading Deck
CytRx's stock spike proves to be no fluke with another 20% share gain 12:39 p.m. Dec. 12, 2013 - Russ Britt
MasterCard, Visa among top S&P gainers; Avon in red 5:27 p.m. Dec. 11, 2013 - Sue Chang
Cancer drug test results send CytRx shares soaring by 75% 11:48 a.m. Dec. 11, 2013 - Russ Britt
CytRx jumps on results of aldoxorubicin trial 10:47 a.m. Dec. 11, 2013 - MarketWatch.com
Yum shares drop on outlook, soft China sales 6:10 p.m. Oct. 8, 2013 - Wallace Witkowski
Six companies unveil share, unit offerings 8:45 a.m. Dec. 7, 2012 - MarketWatch.com
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
CytRx prices offering at 20% discount 11:07 a.m. Oct. 18, 2012 - MarketWatch.com
CytRx down 20.6% in premarket 8:59 a.m. Oct. 18, 2012 - Steve Gelsi
CytRx rallies 27% on drug study update 12:49 p.m. July 25, 2012 - Val Brickates Kennedy
CytRx falls 12% in morning trading 11:02 a.m. June 4, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:40 p.m. April 28, 2011 - Kate Gibson
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:00 p.m. June 30, 2009 - MarketWatch
Drug stocks retract; Vical, Geron, Novavax soar 2:29 p.m. June 30, 2009 - Val Brickates Kennedy
CytRx files FDA report on halted clinical trial 9:16 a.m. June 30, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:39 p.m. Jan. 22, 2008 - MarketWatch
Drug stocks tumble on U.S. economy jitters; CytRx slumps 2:33 p.m. Jan. 22, 2008 - Val Brickates Kennedy
CytRx halts trial of ALS treatment 8:50 a.m. Jan. 22, 2008 - Angela Moore
Three Lessons From The Galena Scandal 11:02 a.m. Aug. 21, 2014 - Seeking Alpha
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 5:22 p.m. Aug. 4, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 11:11 a.m. July 8, 2014 - Barrons.com
Five Analyst Stock Picks With 100% or More Implied Upside 8:31 a.m. June 7, 2014 - 247WallSt.com
Celldex: The Race Leader In Glioblastoma Multiforme 3:17 p.m. May 29, 2014 - Seeking Alpha
Aldoxorubicin increases PFS 7:53 a.m. May 28, 2014 - Seeking Alpha
Six Unusual Hot Stocks on the Move Monday Morning 8:14 a.m. May 5, 2014 - 247WallSt.com
Interesting CYTR Put And Call Options For December 20th 12:51 p.m. April 22, 2014 - TheStreet.com
CytRx shares pop premarket 8:32 a.m. April 3, 2014 - Seeking Alpha
CytRx drug for soft-tissue sarcomas gets orphan status in Europe 8:21 a.m. March 31, 2014 - Seeking Alpha
Behind The Scenes With Proactive, Inovio And Unilife 9:45 a.m. March 27, 2014 - Seeking Alpha
Stock Pumping Is Tainting Many Financial Websites 1:30 p.m. March 25, 2014 - Barrons.com
Seeking Alpha Needs to Take Stock of its Policies 10:07 a.m. March 24, 2014 - Barrons.com
Galena: A Good Investment Gone Bad 9:02 a.m. March 18, 2014 - Seeking Alpha
An Insider's Tale of a Stock Promotion Plan 7:39 p.m. March 14, 2014 - Barrons.com
Behind The Scenes With Dream Team, CytRx And Galena 9:30 a.m. March 13, 2014 - Seeking Alpha
CytRx set to begin phase 3 clinical trial for aldoxorubicin 8:33 a.m. March 5, 2014 - Seeking Alpha
10-K: CYTRX CORP 7:04 a.m. March 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
CytRx's Aldoxorubicin's Potential Is Underestimated, Creating A Buying Opportunity 10:06 a.m. Feb. 7, 2014 - Seeking Alpha
CytRx Flushed Its Shareholders, Even If It Needed the Capital 8:16 a.m. Feb. 1, 2014 - 247WallSt.com
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx CorporationRegarding Possible Breaches of Fiduciary Duty 6:03 p.m. Aug. 11, 2014 - BusinessWire - BZX
Technical Recap on Biotech Equities -- CytRx, AVEO Pharma, Mast Therapeutics, Immunomedics, and Dynavax Technologies 9:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Oral Presentation of CytRx’s Aldoxorubicin Phase 2b Clinical Trial in Soft Tissue Sarcoma Highlighted in The Lancet Oncology 6:00 a.m. Aug. 7, 2014 - BusinessWire - BZX
CytRx Reports 2014 Second Quarter Financial Results 6:00 a.m. Aug. 6, 2014 - BusinessWire - BZX
Former Louisiana Attorney General and KSF Announce Appointment as Lead Counsel in CytRx Securities Fraud Lawsuit: Secondary Offering Shareholders (January 31, 2014) Should Inquire for More Information -- CYTR 6:00 p.m. Aug. 5, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx Corporation Regarding Possible Breaches of Fiduciary Duty 6:56 p.m. July 9, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks -- Research on Insmed, Peregrine Pharma, CytRx, and Celldex Therapeutics 6:40 a.m. June 30, 2014 - PR Newswire - PRF
CytRx Added to Russell 3000® and Russell 2000® Indexes 6:01 a.m. June 30, 2014 - BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos 5:20 a.m. June 12, 2014 - PR Newswire - PRF
CytRx to Present at the Jefferies 2014 Global Healthcare Conference 6:01 a.m. May 29, 2014 - BusinessWire - BZX
CytRx Highlights Aldoxorubicin Data from its Global Phase 2b Clinical Trial in First-Line Soft Tissue Sarcoma 6:01 a.m. May 28, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx Corporation and Certain Officers - CYTR 6:15 p.m. May 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline -- CYTR 11:46 a.m. May 8, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR 12:33 p.m. May 6, 2014 - GlobeNewswire
Hagens Berman: 7 Days Remain Until May 13, 2014 Lead Plaintiff Deadline in CytRx Securities Fraud Class Action 12:26 p.m. May 6, 2014 - PR Newswire - PRF
CytRx Reports Completed Phase 1b/2 Progression-Free Survival and Overall Survival Aldoxorubicin Data in Second-Line Soft Tissue Sarcoma 6:01 a.m. May 5, 2014 - BusinessWire - BZX
Pre-Market Review on Top Gainers -- Research on SouFun Holdings, CytRx, Iridium Communications, and Qihoo 360 Technology 8:12 a.m. May 2, 2014 - PR Newswire - PRF
CYTRX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CytRx Corporation - CYTR 10:01 p.m. May 1, 2014 - GlobeNewswire
CytRx Reports 2014 First Quarter Financial Results 6:02 a.m. May 1, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼